Phase III Clinical Trials of the Cell Differentiation Agent-2 (CDA-2): Therapeutic Efficacy on Breast Cancer, Non-Small Cell Lung Cancer and Primary Hepatoma
摘要
引用本文(GB/T 7714)
Feng-Yi, Feng, Qing Qing, 等. Phase III Clinical Trials of the Cell Differentiation Agent-2 (CDA-2): Therapeutic Efficacy on Breast Cancer, Non-Small Cell Lung Cancer and Primary Hepatoma[J]. 中国肿瘤临床:英文版, 2005.
引文网络
本站仅收录题录与摘要供学习参考,全文版权归属出版方;如有侵权请联系我们删除。